News
From Autos to Pharma, CEOs Navigate Tariff Impacts ...
ABL Bio Inc., a South Korean biotech company, will license out its proprietary blood-brain barrier shuttle platform, called the Grabody-B, to UK-based pharmaceutical giant GSK plc in a deal expected ...
8d
inews.co.uk on MSNChinese agents followed us after Parliament visit, says Briton jailed in ShanghaiA British former journalist and private investigator, once jailed in China, believes a team of Chinese agents tracked him and ...
Novo Nordisk announced it will work with the biotech Septerna to develop oral GLP-1 obesity drugs in a deal worth up to $2.2 billion, including $200 million upfront. GSK is paying $1.2 billion upfront ...
In another note of news, a key aide to HHS Secretary Robert F. Kennedy Jr. said that popular GLP-1 weight loss drugs -- Novo Nordisk's ( NVO) Wegovy (semaglutide) and Eli Lilly's ( LLY) Zepbound ...
Drugmaker's "three most senior" R&D officials "deliberately slow[ed] testing" so it would end after 2020 election, ...
The House Judiciary Committee revealed Thursday that Pfizer’s former Global Head of Vaccines Research and Development, Dr.
The GOP-led House Judiciary Committee is investigating allegations that Pfizer delayed its COVID-19 vaccine testing until ...
On Nov. 9, 2020, Pfizer and partner BioNTech announced that the vaccine had met the first effectiveness bar in a key study.
The GOP-led House Judiciary Committee is investigating Pfizer's COVID-19 vaccine development timeline. They are focusing on ...
For 2025/2026, undergraduate places are offered for 39 weeks, from Saturday 20 September 2025 to Saturday 20 June 2026. The fees in the table below are for the 2025/2026 academic year.
[LONDON] GSK agreed to buy an experimental medicine to treat liver disease for as much as US$2 billion as the UK drugmaker seeks to shore up its pipeline of new medicines. The treatment developed by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results